Thomas Flaten
Stock Analyst at Lake Street
(0.46)
# 2415
Out of 5,329 analysts
43
Total ratings
34.48%
Success rate
-1.70%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
OCX OncoCyte | Initiates Coverage On: Buy | 5 | 3.12 | 60.26% | 5 | Mar 28, 2025 | |
OPTN OptiNose | Downgrades: Hold | 17 9 | 9.38 | -4.05% | 5 | Mar 20, 2025 | |
CKPT Checkpoint Therapeut... | Downgrades: Hold | 7 5 | 4.12 | -0.49% | 5 | Mar 10, 2025 | |
AQST Aquestive Therapeuti... | Maintains: Buy | 10 8 | 3.01 | 165.78% | 2 | Mar 7, 2025 | |
EVAX Evaxion Biotech | Maintains: Buy | 35 6 | 1.55 | 287.1% | 2 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 7 9 | 3.85 | 133.77% | 2 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 34 40 | 19.31 | 107.15% | 5 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 9 | 6.91 | 30.25% | 1 | Sep 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 1 | n/a | n/a | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 4 3 | 0.65 | 361.54% | 3 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 19 11 | 2.45 | 348.98% | 3 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 5 3 | n/a | n/a | 2 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 34 25 | 24.6 | 1.63% | 2 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 14400 1440 | 2.92 | 49215.07% | 2 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 14 8 | 4.19 | 90.93% | 1 | Jul 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | May 13, 2022 |